317 related articles for article (PubMed ID: 10677093)
1. A randomized, 12-year primary-prevention trial of beta carotene supplementation for nonmelanoma skin cancer in the physician's health study.
Frieling UM; Schaumberg DA; Kupper TS; Muntwyler J; Hennekens CH
Arch Dermatol; 2000 Feb; 136(2):179-84. PubMed ID: 10677093
[TBL] [Abstract][Full Text] [Related]
2. Occurrence of other cancers among patients with prior basal cell and squamous cell skin cancer.
Karagas MR; Greenberg ER; Mott LA; Baron JA; Ernster VL
Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):157-61. PubMed ID: 9488591
[TBL] [Abstract][Full Text] [Related]
3. Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy. For The Skin Cancer Prevention Study Group.
Karagas MR; McDonald JA; Greenberg ER; Stukel TA; Weiss JE; Baron JA; Stevens MM
J Natl Cancer Inst; 1996 Dec; 88(24):1848-53. PubMed ID: 8961975
[TBL] [Abstract][Full Text] [Related]
4. Sun protection for preventing basal cell and squamous cell skin cancers.
Sánchez G; Nova J; Rodriguez-Hernandez AE; Medina RD; Solorzano-Restrepo C; Gonzalez J; Olmos M; Godfrey K; Arevalo-Rodriguez I
Cochrane Database Syst Rev; 2016 Jul; 7(7):CD011161. PubMed ID: 27455163
[TBL] [Abstract][Full Text] [Related]
5. Effect of NSAIDs on the recurrence of nonmelanoma skin cancer.
Grau MV; Baron JA; Langholz B; Karagas M; Greenberg ER; Stukel TA; Mandel JS
Int J Cancer; 2006 Aug; 119(3):682-6. PubMed ID: 16496410
[TBL] [Abstract][Full Text] [Related]
6. Selenium supplementation and secondary prevention of nonmelanoma skin cancer in a randomized trial.
Duffield-Lillico AJ; Slate EH; Reid ME; Turnbull BW; Wilkins PA; Combs GF; Park HK; Gross EG; Graham GF; Stratton MS; Marshall JR; Clark LC;
J Natl Cancer Inst; 2003 Oct; 95(19):1477-81. PubMed ID: 14519754
[TBL] [Abstract][Full Text] [Related]
7. Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012.
Rogers HW; Weinstock MA; Feldman SR; Coldiron BM
JAMA Dermatol; 2015 Oct; 151(10):1081-6. PubMed ID: 25928283
[TBL] [Abstract][Full Text] [Related]
8. A randomized trial of beta carotene and age-related cataract in US physicians.
Christen WG; Manson JE; Glynn RJ; Gaziano JM; Sperduto RD; Buring JE; Hennekens CH
Arch Ophthalmol; 2003 Mar; 121(3):372-8. PubMed ID: 12617708
[TBL] [Abstract][Full Text] [Related]
9. Nonsteroidal anti-inflammatory drugs and the risk of nonmelanoma skin cancer.
Reinau D; Surber C; Jick SS; Meier CR
Int J Cancer; 2015 Jul; 137(1):144-53. PubMed ID: 25418602
[TBL] [Abstract][Full Text] [Related]
10. Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis.
Marcil I; Stern RS
Arch Dermatol; 2000 Dec; 136(12):1524-30. PubMed ID: 11115165
[TBL] [Abstract][Full Text] [Related]
11. Effect of retinol in preventing squamous cell skin cancer in moderate-risk subjects: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group.
Moon TE; Levine N; Cartmel B; Bangert JL; Rodney S; Dong Q; Peng YM; Alberts DS
Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):949-56. PubMed ID: 9367069
[TBL] [Abstract][Full Text] [Related]
12. Long-term beta-carotene supplementation and risk of type 2 diabetes mellitus: a randomized controlled trial.
Liu S; Ajani U; Chae C; Hennekens C; Buring JE; Manson JE
JAMA; 1999 Sep; 282(11):1073-5. PubMed ID: 10493207
[TBL] [Abstract][Full Text] [Related]
13. Beta-carotene supplementation and incidence of cancer and cardiovascular disease: the Women's Health Study.
Lee IM; Cook NR; Manson JE; Buring JE; Hennekens CH
J Natl Cancer Inst; 1999 Dec; 91(24):2102-6. PubMed ID: 10601381
[TBL] [Abstract][Full Text] [Related]
14. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group.
Clark LC; Combs GF; Turnbull BW; Slate EH; Chalker DK; Chow J; Davis LS; Glover RA; Graham GF; Gross EG; Krongrad A; Lesher JL; Park HK; Sanders BB; Smith CL; Taylor JR
JAMA; 1996 Dec; 276(24):1957-63. PubMed ID: 8971064
[TBL] [Abstract][Full Text] [Related]
15. Aspirin and nonsteroidal anti-inflammatory drug use and keratinocyte cancers: a large population-based cohort study of skin cancer in Australia.
Pandeya N; Olsen CM; Thompson BS; Dusingize JC; Neale RE; Green AC; Whiteman DC;
Br J Dermatol; 2019 Oct; 181(4):749-760. PubMed ID: 30920641
[TBL] [Abstract][Full Text] [Related]
16. Effect of non-steroidal anti-inflammatory drugs on non-melanoma skin cancer incidence in the SKICAP-AK trial.
Clouser MC; Roe DJ; Foote JA; Harris RB
Pharmacoepidemiol Drug Saf; 2009 Apr; 18(4):276-83. PubMed ID: 19226541
[TBL] [Abstract][Full Text] [Related]
17. Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial.
Christian JB; Lapane KL; Hume AL; Eaton CB; Weinstock MA;
J Natl Cancer Inst; 2008 Sep; 100(17):1223-32. PubMed ID: 18728281
[TBL] [Abstract][Full Text] [Related]
18. Does daily use of sunscreen or beta-carotene supplements prevent skin cancer in healthy adults?
Del Mar C
West J Med; 2000 Nov; 173(5):332. PubMed ID: 11069872
[No Abstract] [Full Text] [Related]
19. Increasing skin cancer incidence in young, affluent, urban populations: a challenge for prevention.
Deady S; Sharp L; Comber H
Br J Dermatol; 2014 Aug; 171(2):324-31. PubMed ID: 24666396
[TBL] [Abstract][Full Text] [Related]
20. A phase III skin cancer chemoprevention study of DFMO: long-term follow-up of skin cancer events and toxicity.
Kreul SM; Havighurst T; Kim K; Mendonça EA; Wood GS; Snow S; Borich A; Verma A; Bailey HH
Cancer Prev Res (Phila); 2012 Dec; 5(12):1368-74. PubMed ID: 23060038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
